NextGen Healthcare Successfully
Completes CMS Claims Attachment Pilot
Horsham, Pa.--November
10, 2005--NextGen Healthcare Information Systems Inc., a subsidiary of Quality Systems, Inc. (Nasdaq: QSII), today announced that it has completed a pilot project with Empire Medicare Services, a fee-for-service Medicare contractor, and the Workgroup for Electronic Data Interchange (WEDI) Foundation to facilitate the use of electronic attachments between a health plan and its providers. The pilot program, which was funded for Empire Medicare Services and WEDI by the Centers for Medicare & Medicaid Services (CMS), tested the use of electronic claims attachments in accordance with HIPAA’s transaction code sets, including ANSI 275 and 277.
Using the integrated claims, clinical and imaging products provided by NextGen Healthcare, Empire Medicare Services electronically requested additional information from participating providers to complete the full claims cycle from the initial 837 transaction to the 275 claim attachment submission. The use of Logical Observation Identifier Names and Codes (LOINC) codes within each request was used to specify the information being requested and provided the level of detail necessary for the provider to successfully adjudicate the claim. Each LOINC code was mapped to the existing information in the provider's system, such as EMR documents, scanned images and lab results, to produce the electronic attachment.
NextGen Healthcare recently presented the results of the pilot project at the Second Annual Claims Attachment Forum, which was sponsored by the Association for Electronic Healthcare Transactions (AFEHCT), WEDI, Health Level Seven (HL7) and ASC X12.
About Quality Systems, Inc.
Quality Systems,
Inc. and its NextGen Healthcare Information
Systems subsidiary develop and market
computer-based practice management, patient
records, and connectivity applications
for medical and dental group practices.
Visit www.qsii.com and www.nextgen.com for
additional information.
This news release
may contain forward-looking statements
within the meaning of the federal securities
laws. Statements regarding future events,
developments, and the Company's future
performance, as well as management's
expectations, beliefs, intentions, plans,
estimates, or projections relating to
the future (including, without limitation,
statements concerning revenue and net
income) are forward-looking statements
within the meaning of these laws and
involve a number of risks and uncertainties.
Moreover, these forward-looking statements
are subject to a number of risks and
uncertainties, some of which are outlined
below. As a result, actual results may
vary materially from those anticipated
by the forward-looking statements. Among
the important factors that could cause
actual results to differ materially from
those indicated by such forward-looking
statements are: the volume and timing
of systems sales and installations; length
of sales cycles and the installation
process; the possibility that products
will not achieve or sustain market acceptance;
seasonal patterns of sales and customer
buying behavior; the timing, cost, and
success or failure of new product and
service introductions, development, and
product upgrade releases; undetected errors
or bugs in software; changing economic,
political, or regulatory influences in
the health-care industry; changes in product-pricing
policies; availability of third-party
products and components; competitive pressures,
including product offerings, pricing,
and promotional activities; the Company's
ability or inability to attract and retain
qualified personnel; possible regulation
of the Company's software by the U.S.
Food and Drug Administration; uncertainties
concerning threatened, pending, and new
litigation against the Company, including
related professional services fees; uncertainties
concerning the amount and timing of professional
fees incurred by the Company generally;
changes of accounting estimates and assumptions
used to prepare the prior periods' financial statements; general economic conditions;
and the risk factors detailed from
time to time in Quality Systems' periodic
reports and registration statements
filed with the Securities and Exchange
Commission. A significant portion of
the Company's quarterly sales of software
product licenses and computer hardware
is concluded in the last month of the
fiscal quarter, generally with a concentration
of such revenues earned in the final
ten business days of that month. Due
to these and other factors, the Company's
revenues and operating results are
very difficult to forecast. A major
portion of the Company's costs and
expenses, such as personnel and facilities,
are of a fixed nature and, accordingly,
a shortfall or decline in quarterly
and/or annual revenues typically results
in lower profitability or losses. As
a result, comparison of the Company's
period-to-period financial performance
is not necessarily meaningful and should
not be relied upon as an indicator
of future performance. The Company
undertakes no obligation to publicly
update any forward-looking statements,
whether as a result of new information,
future events, or otherwise.
Contact:
NextGen Healthcare Information Systems
Jennifer Kuesel, 215-657-7010
JKuesel@nextgen.com
